Abstract
IC/PBS can be a chronic debilitating bladder condition that has eluded a major diagnostic or treatment breakthrough since the first cases were reported nearly 130 years ago. This condition is defined by a constellation of symptoms including urinary urgency, frequency, and bladder pain without identifiable causes. Potential etiologic mechanisms include bladder urothelial dysfunction, immune dysregulation, pelvic floor myalgia, and nervous system dysfunction. The etiology of IC/PBS is likely multifactorial. Our ability to treat this condition effectively is also limited by the heterogeneity of presentation (varying phenotypes). Very few studies of high-level evidence are available to direct treatment strategies. Since there have been many reviews detailing diagnosis and treatment of IC/PBS, rather than be repetitive, we sought to frame this review by exploring six questions: What is the historical context of IC/PBS? Is it a bladder-based disease? What other conditions are associated with IC/PBS? What does “early” IC/PBS look like, and can this stage be diagnosed? With varying phenotypic presentations, what is the best approach to treat IC/PBS? And finally, what is the history and future of IC/PBS research? The fruits of research to date have minimally impacted care of IC/PBS patients. A different approach with increased research funding is needed to find new things under the sun that will advance the art and science of IC/PBS.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Dyer AJ et al. Painful bladder syndrome: an update and review of current management strategies. Curr Urol Rep. 2014;15(2):384.
Colaco MA et al. Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome. Curr Urol Rep. 2013;14(5):442–7.
Kartha GK et al. Clinical phenotyping of urologic pain patients. Curr Opin Urol. 2013;23(6):560–4.
Chrysanthopoulou EL, et al. Challenges and current evidence on the management of bladder pain syndrome. Neurourol Urodyn. 2013 Aug 14, epub ahead of print.
Tirlapur SA et al. Nerve stimulation for chronic pelvic pain and bladder pain syndrome: a systematic review. Acta Obstet Gynecol Scand. 2013;92(8):881–7.
Offiah I et al. Interstitial cystitis/bladder pain syndrome: diagnosis and management. Int Urogynecol J. 2013;24(8):1243–56. These six references are detailed reviews related to evaluation and management of IC/PBS. The reviews are from both urologic and gynecologic literature.
Hanno PM et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70. An expert panel reviewed the literature in IC/PBS evaluation and management. This panel then made a series of recommendations based on strength of the data resulting in these guidelines.
Christmas TJ. Historical aspects of interstitial cystitis. In: Sant GR, editor. Interstitial cystitis, chapt. 1. Philadelphia: Lippincott-Raven; 1997. p. 108.
Parrish J. Tic doloureux of the urinary bladder. In: Practical observations on strangulated hernia and some of the diseases of the urinary organs. Philadelphia: Key and Biddle; 1836. p. 309–13.
Walsh A. Historical perspective. In: Hanno PM, Staskin DR, Krane RJ, Wein AJ, editors. Interstitial cystitis, chapt. 2. London: Springer-Verlag; 1990. p. 17.
Hunner GL. A rare type of bladder ulcer in women: report of cases. Trans South Surg Gynecol Assoc. 1915;27:247.
Messing EM et al. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology. 1978;12(4):381–92.
Nigro DA et al. Associations among cystoscopic and urodynamic findings for women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology. 1997;49(5A Suppl):86–92.
Sun Y et al. Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: does ESSIC criteria change the response rate? Neurourol Urodyn. 2014;33(3):341–4.
Abrams P et al. The standardization of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Am J Obstet Gynecol. 2002;187(1):116–26.
Ueda T et al. Proceedings of the International Consultations on Interstitial Cystitis, Kyoto Japan, March 29–30, 2003. Int J Urol. 2003;10(suppl):S1–S70.
Nordling J et al. Primary evaluations of patients suspected of having interstitial cystitis (IC). Eur Urol. 2004;45(5):662–9.
Cervigini M, et al. (editors). International Consultation on Interstitial Cystitis–Rome (ICICR) and Proceedings of the Multinational Interstitial Cystitis Association (MICA), September 21–22, 2004. Int Urogynecol J. 2005;16:S1–S34.
Hanno P et al. Bladder pain syndrome committee of the international consultation on incontinence. Neurourol Urodyn. 2010;29(1):191–8.
Wilt T, et al. Interstitial cystitis epidemiology task force meeting, October 29, 2003; National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, Maryland, http://archives.niddk.nih.gov/ic2003/TaskForce_Meeting_Report.pdf.
Chelimsky G et al. Co-morbidities of interstitial cystitis. Front Neurosci. 2012;6:114.
Warren JW et al. Antecedent nonbladder syndromes in case–control study of interstitial cystitis/painful bladder syndrome. Urology. 2009;73(1):52–7.
Clemens JQ et al. Temporal ordering of interstitial cystitis/bladder pain syndrome and non-bladder conditions. Urology. 2012;80(6):1227–31.
Warren JW et al. The number of existing functional somatic syndromes (FSSs) is an important risk factor for new, different FSSs. J Psychosom Res. 2013;74(1):12–7.
Martínez-Martínez LA et al. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case–control studies. J Clin Rheumatol. 2014;20(3):146–50. This paper hypothesized that dysfunction of the sympathetic nervous system links IC/PBS with functional somatic syndromes.
MacMahon B et al. Coffee and cancer of the pancreas. N Engl J Med. 1981;304(11):630–3.
Feinstein AR et al. Coffee and pancreatic cancer. The problems of etiologic science and epidemiologic case–control research. JAMA. 1981;246(9):957–61.
Hardell L et al. Further aspects on cellular and cordless telephones and brain tumours. Int J Oncol. 2003;22(2):399–407.
Lönn S et al. Long-term mobile phone use and brain tumor risk. Am J Epidemiol. 2005;161(6):526–35.
Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
Warren JW et al. Interstitial cystitis/bladder pain syndrome and nonbladder syndromes: facts and hypotheses. Urology. 2011;78(4):727–32. This reference proposes hypothesis testing in studying link between functional somatic syndromes and IC/PBS.
Tirlapur SA et al. The 'evil twin syndrome' in chronic pelvic pain: a systematic review of prevalence studies of bladder pain syndrome and endometriosis. Int J Surg. 2013;11(3):233–7.
Cheng C et al. Diagnosis of interstitial cystitis/bladder pain syndrome in women with chronic pelvic pain: a prospective observational study. Int Urogynecol J. 2012;23(10):1361–6.
Chung MK et al. Intersitital cystitis and endometriosis in patients with chronic pelvic pain: the "Evil Twins" syndrome. JSLS. 2005;9(1):25–9.
Aaron LA et al. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med. 2001;134(9 Pt 2):868–81.
Nickel JC et al. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. J Urol. 2009;182(1):155–60.
Stanford E et al. There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(5):551–4.
Warren JW et al. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urology. 2008;71(6):1085–90.
Hand JR. Interstitial cystitis. J Urol. 1949;61(2):291–310.
Porru D et al. Different clinical presentation of interstitial cystitis syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2004;15(3):198–202.
Gillenwater JY et al. Summary of the national institute of arthritis, diabetes, digestive and kidney diseases workshop on interstitial cystitis, national institutes of health, Bethesda, Maryland, August 28–29, 1987. J Urol. 1987;140(1):203–6.
Propert KJ et al. Prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group. J Urol. 2000;163(5):1434–9.
Warren JW, et al. Urinary symptoms as a prodrome of bladder pain syndrome/interstitial cystitis. Urology. 2014 Mar 25; Epub ahead of print. This reference considers what prodromal symptoms occur prior to development of IC/PBS.
Fall M et al. Methods and incentives for the early diagnosis of bladder pain syndrome/interstitial cystitis. Expert Opin Med Diagn. 2013;7(1):17–24.
Bohne AW et al. Interstitial cystitis: an adjunct in its treatment. AMA Arch Surg. 1954;69(6):831–4.
Simon LJ et al. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology. 1997;49(5A Suppl):64–75.
Kirkemo A et al. Associations among urodynamic findings and symptoms in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology. 1997;49(5A Suppl):76–80.
Messing E et al. Associations among cystoscopic findings and symptoms and physical examination findings in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology. 1997;49(5A Suppl):81–5.
Rovner E et al. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology. 2000;56(6):940–5.
Tomaszewski JE et al. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology. 2001;57(6 Suppl 1):67–81.
Sant GR et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003;170(3):810–5.
Mayer R et al. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol. 2005;173(4):1186–91.
Foster HE et al. Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol. 2010;183(5):1853–8.
Yang CC et al. Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. J Urol. 2011;185(3):901–6.
FitzGerald MP et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187(6):2113–8. This randomized study was the first one to examine pelvic floor myofascial release in women with IC/PBS.
Fitzgerald MP et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2013;189(1 Suppl):S75–85.
Keay S et al. A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study. BMC Urol. 2012;12:17. This reference details a mouse model for IC/PBS based on discovery of APF ffrom human IC/PBS urinary specimens. This is a translational animal model with high clinical relevancy.
Keay SK et al. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci U S A. 2004;101(32):11803–8.
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.
Phillips K et al. Central pain mechanisms in chronic pain states–maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011;25(2):141–54.
You S et al. ‘Omics’ approaches to understand interstitial cystitis/painful bladder syndrome. Int Neurourol J. 2012;16(4):159–68. This reference reviews modern biomarker discovery techniques and its applications to IC/PBS research.
Compliance with Ethics Guidelines
Conflict of Interest
Marsha K. Guess declares that she has no conflict of interest.
Toby C. Chai reports personal fees from Taris Biomedical; personal fees from Allergan; and personal fees from Ion Channel, Inc. from outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guess, M.K., Chai, T.C. Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): Is There Anything New under the Sun?. Curr Obstet Gynecol Rep 3, 165–171 (2014). https://doi.org/10.1007/s13669-014-0086-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13669-014-0086-7